As of Feb 05
| -0.07 / -0.98%|
The 1 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a -14.89% decrease from the last price of 7.05.
The current consensus among 1 polled investment analysts is to Hold stock in Sinovac Biotech Ltd. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.